Literature DB >> 18207234

Inflammatory cytokine removal by an activated carbon device in a flowing system.

Susan R Sandeman1, Carol A Howell, Sergey V Mikhalovsky, Gary J Phillips, Andrew W Lloyd, J Graham Davies, Stephen R Tennison, Anthony P Rawlinson, Oleksaudr P Kozynchenko.   

Abstract

A prototype in-line filtration/adsorption device has been developed using novel synthetic pyrolysed carbon monoliths with controlled mesoporous domains of 2-50nm. Porosity was characterized by SEM and porosimetry. Removal of inflammatory cytokines TNF, IL-6, IL-1beta and IL-8 was assessed by filtering cytokine spiked human plasma through the walls of the carbon modules under pressure. The effect of carbon filtration on plasma clotting response and total plasma protein concentration was also assessed. Significant removal of the cytokines IL-6, IL-1beta and IL-8 was observed. Initially marked TNF removal diminished over time. The coagulation studies indicated that the carbon device does not exacerbate the propensity of blood plasma to clot. The total plasma protein concentration remained constant. The device offers a broader approach to the treatment of systemic inflammatory response syndrome (SIRS) by the removal of inflammatory mediators central to its progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207234     DOI: 10.1016/j.biomaterials.2007.12.013

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

Review 1.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

2.  Preparation of sulfonated porous carbon nanotubes/activated carbon composite beads and their adsorption of low density lipoprotein.

Authors:  Yuemei Lu; Qianming Gong; Fangping Lu; Ji Liang; Lijun Ji; Qingdong Nie; Xiumei Zhang
Journal:  J Mater Sci Mater Med       Date:  2011-06-08       Impact factor: 3.896

3.  An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.

Authors:  Susan R Sandeman; Carol A Howell; Gary J Phillips; Yishan Zheng; Guy Standen; Robert Pletzenauer; Andrew Davenport; Kolitha Basnayake; Owen Boyd; Stephen Holt; Sergey V Mikhalovsky
Journal:  J Mater Sci Mater Med       Date:  2014-02-27       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.